SCT to present candidate selection workflow at Antibody Engineering & Therapeutics
11 December 2019
San Diego, CA – [December 11th, 2019] – Single Cell Technology, Inc. (SCT) announced their candidate selection workflow at this year's Antibody Engineering & Therapeutics conference in San Diego, CA. Antibody Engineering & Therapeutics is being held this year at the Marriott Marquis.
This workflow demonstrates what partners and customers can do with the data from SCT's process, AbTheneum™. "This workflow has been an effort of the last year that we are really excited to present," commented Chun-Nan Chen. "We are showing the process of validating a lead molecule from our discovery process, because not a lot of parties know how to handle all the antibodies that we discover," he added. The workflow is demonstrated using hot oncology targets including BCMA, TIGIT, and TIM3.
The talk, titled "Antigen to Preclinical Leads in 180 Days" will be delivered on Wednesday, December 11, with the SCT team standing by at Booth 404 to take questions and inquiries.